ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion

Advances in Nutrition

Volumn 5, Issue 3, 2014, Pages 268-277

  Barrett, Erin Cernkovich ^a   McBurney, Michael I ^a   Ciappio, Eric D ^a  

^a DSM NUTRITIONAL PRODUCTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ANIMAL; BRAIN; BRAIN CONCUSSION; BRAIN INJURIES; COGNITION; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; HUMAN; MEMORY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; BRAIN; BRAIN CONCUSSION; BRAIN INJURIES; COGNITION; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; HUMANS; MEMORY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84910127021     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.113.005280     Document Type: Review

References (93)

1. Centers for Disease Control and Prevention. Heads up: facts for physicians about mild traumatic brain injury (MTBI) 2007 [cited 2013 July 19]. Available from: http://www.cdc.gov/concussion/headsup/pdf/Facts_for_ Physicians_booklet-a.pdf.
2. Giza CC, Kutcher JS, Ashwal S, Barth J, Getchius TS, Gioia GA, Gronseth GS, Guskiewicz K, Mandel S, Manley G, et al. Summary of evidencebased guideline update: evaluation and management of concussion in sports: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;80:2250-7.
3. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil. 2006;21:544-8.
4. Centers for Disease Control and Prevention. Nonfatal traumatic brain injuries related to sports and recreation activities among persons aged #19 years-United States, 2001-2009. MMWR Morb Mortal Wkly Rep. 2011;60:1337-42.
5. Lincoln AE, Caswell SV, Almquist JL, Dunn RE, Norris JB, Hinton RY. Trends in concussion incidence in high school sports: a prospective 11-year study. Am J Sports Med. 2011;39:958-63.
6. Finkelstein EA, Corso PS, Miller TR. The incidence and economic burden of injuries in the United States. New York: Oxford University Press; 2006.
7. McCrory P, MeeuwisseW, Aubry M, Cantu B, Dvorak J, Echemendia R, Engebretsen L, Johnston K, Kutcher J, Raftery M, et al. Consensus statement on Concussion in Sport-the 4th International Conference on Concussion in Sport held in Zurich, November 2012. J Sci Med Sport. 2013;16:178-89.
8. Shrey DW, Griesbach GS, Giza CC. The pathophysiology of concussions in youth. Phys Med Rehabil Clin N Am. 2011;22:577-602.
9. Field M, Collins MW, Lovell MR, Maroon J. Does age play a role in recovery from sports-related concussion? A comparison of high school and collegiate athletes. J Pediatr. 2003;142:546-53.
10. Guskiewicz KM, McCrea M, Marshall SW, Cantu RC, Randolph C, Barr W, Onate JA, Kelly JP. Cumulative effects associated with recurrent concussion in collegiate football players: the NCAA Concussion Study. JAMA. 2003;290:2549-55.
11. Prins ML, Giza CC. Repeat traumatic brain injury in the developing brain. Int J Dev Neurosci. 2012;30:185-90.
12. Harmon KG, Drezner J, GammonsM, Guskiewicz K, HalsteadM, Herring S, Kutcher J, Pana A, Putukian M, RobertsW. American Medical Society for Sports Medicine position statement: concussion in sport. Clin J Sport Med. 2013;23:1-18.
13. McCrory P, Meeuwisse WH, Kutcher JS, Jordan BD, Gardner A. What is the evidence for chronic concussion-related changes in retired athletes: behavioural, pathological and clinical outcomes? Br J Sports Med. 2013;47:327-30.
14. Guskiewicz KM, Marshall SW, Bailes J, McCrea M, Cantu RC, Randolph C, Jordan BD. Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery. 2005;57:719-26.
15. Guskiewicz KM, Marshall SW, Bailes J, McCrea M, Harding HP Jr, Matthews A, Mihalik JR, Cantu RC. Recurrent concussion and risk of depression in retired professional football players. Med Sci Sports Exerc. 2007;39:903-9.
16. Kerr ZY, Marshall SW, Harding HP Jr, Guskiewicz KM. Nine-year risk of depression diagnosis increases with increasing self-reported concussions in retired professional football players. Am J SportsMed. 2012;40:2206-12.
17. Institute of Medicine, National Research Council. Sports-related concussions in youth: improving the science, changing the culture. Washington, DC: National Academies Press; 2013.
18. Giza CC, Hovda DA. The neurometabolic cascade of concussion. J Athl Train. 2001;36:228-35.
19. Barkhoudarian G, Hovda DA, Giza CC. The molecular pathophysiology of concussive brain injury. Clin Sports Med. 2011;30:33-48.
20. Dashnaw ML, Petraglia AL, Bailes JE. An overview of the basic science of concussion and subconcussion: where we are and where we are going. Neurosurg Focus. 2012;33:E5:1-9.
21. Blaylock RL, Maroon J. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-a unifying hypothesis. Surg Neurol Int. 2011;2:107.
22. Petraglia AL, Maroon JC, Bailes JE. From the field of play to the field of combat: a review of the pharmacological management of concussion. Neurosurgery. 2012;70:1520-33.
23. Institute of Medicine. Nutrition and traumatic brain injury: improving acute and subacute health outcomes in military personnel.Washington, DC: National Academies Press; 2011.
24. Lauritzen L, Hansen H, Jorgensen M, Michaelsen K. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res. 2001;40:1-94.
25. Salem N, Litman B, Kim H, Gawrisch K. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001;36:945-59.
26. Ryan AS, Astwood JD, Gautier S, Kuratko CN, Nelson EB, Salem N Jr. Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids. 2010;82:305-14.
27. Kuratko CN, Barrett EC, Nelson EB, Salem N Jr. The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: a review. Nutrients. 2013;5:2777-810.
28. Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ. Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: a cross-sectional analysis from the DOLAB study. PLoS One. 2013;8:e66697.
29. McNamara RK, Jandacek R, Tso P, Weber W, Chu WJ, Strakowski SM, Adler CM, Delbello MP. Low docosahexaenoic acid status is associated with reduced indices in cortical integrity in the anterior cingulate of healthy male children: a 1H MRS Study. Nutr Neurosci. 2013;16:183-90.
30. Colombo J, Carlson SE, CheathamCL, ShaddyDJ, Kerling EH, Thodosoff JM, Gustafson KM, Brez C. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr. 2013;98:403-12.
31. McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen JC, Alfieri D, Weber W, Jarvis K, DelBello MP, et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr. 2010;91:1060-7.
32. Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P. Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study). PLoS One. 2012;7:e43909.
33. Ryan AS, Nelson EB. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebocontrolled, double-blind study. Clin Pediatr (Phila). 2008;47:355-62.
34. Food and Agriculture Organization. Fats and fatty acids in human nutrition: Report of an Expert Consultation. Rome, Italy: Office of Knowledge Exchange, Research, and Extension, FAO; 2010.
35. Kalmijn S, van BoxtelM, OckeM, VerschurenW, Kromhout D, Launer L. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004;62:275-80.
36. Whalley LJ, Fox H, Wahle K, Starr J, Deary I. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr. 2004;80:1650-7.
37. Titova OE, Sijogren P, Brooks S, Kullberg J, Ax E, Kilander L, Riserus U, Cederholm T, Larsson EM, Johansson L, et al. Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to grey matter volume and cognitive function in elderly. Age (Dordr). 2013;35:1495-505.
38. Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N. Nutrient intake and plasma beta-amyloid. Neurology. 2012;78:1832-40.
39. Tan ZS, Harris W, Beiser A, Au R, Himali J, Debette S, Pikula A, DeCarli C, Wolf P, Vasan R, et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012;78:658-64.
40. Muldoon MF, Ryan C, Sheu L, Yao J, Conklin S, Manuck S. Serum phospholipid docosahexaenoic acid is associated with cognitive functioning during middle adulthood. J Nutr. 2010;140:848-53.
41. Lopez LB, Kritz-Silverman D, Barrett-Connor E. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo Study. J Nutr Health Aging. 2011;15:25-31.
42. Schaefer EJ, Bongard V, Beiser A, Lamon-Fava S, Robins S, Au R, Tucker K, Kyle D, Wilson P, Wolf P. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63:1545-50.
43. MorrisMC, Evans D, Bienias J, Tangney C, Bennett D,Wilson R, Aggarwal N, Schneider J. Consumption of fish and n-3 fatty acids and risk of incident alzheimer disease. Arch Neurol. 2003;60:940-6.
44. Morris MC, Evans D, Tangney C, Bienias J, Wilson R. Fish consumption and cognitive decline with age in a large community study. Arch Neurol. 2005;62:1849-53.
45. Gao Q, Niti M, Feng L, Yap K, Ng T. Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies. J Nutr Health Aging. 2011;15:32-5.
46. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci. 2008;11:75-83.
47. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M, Investigators M. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010;6:456-64.
48. Lee LK, Shahar S, Chin AV, Yusoff NA. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2013;225:605-12.
49. Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, Howe PR. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life,memory and executive function in older adults withmild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr. 2012;107:1682-93.
50. Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29:467-74.
51. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1538-44.
52. Kotani S, Sakaguchi E, Warashina S, Matsukawa N, Ishikura Y, Kiso Y, Sakakibara M, Yoshimoto T, Guo J, Yamashima T. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res. 2006;56:159-64.
53. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63:1402-8.
54. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Jr, Weiner M, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304:1903-11.
55. Lewis M, Ghassemi P, Hibbeln J. Therapeutic use of omega-3 fatty acids in severe head trauma. Am J Emerg Med. 2013;31:273.e5-8.
56. Roberts L, Bailes J, Dedhia H, Zikos A, Singh A, McDowell D, Failinger C, Biundo R, Petrick J, Carpenter J. Surviving a mine explosion. J Am Coll Surg. 2008;207:276-83.
57. Mills JD, Hadley K, Bailes J. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury? Neurosurgery. 2011;68:474-81.
58. Wu A, Ying Z, Gomez-Pinilla F. Omega-3 fatty acid supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury. J Neurotrauma. 2007;24:1587-95.
59. Wu A, Ying Z, Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma. 2004;21:1457-67.
60. Wang T, Van K, Gavitt B, Grayson J, Lu T, Lyeth B, Pichakron K. Effect of fish oil supplementation in a rat model of multiple mild traumatic brain injuries. Restor Neurol Neurosci. 2013;31:647-59.
61. Wu A, Ying Z, Gomez-Pinilla F. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J Neurotrauma. 2011;28:2113-22.
62. Shin SS, Dixon C. Oral fish oil restores striatal dopamine release after traumatic brain injury. Neurosci Lett. 2011;496:168-71.
63. Mills JD, Bailes J, Sedney C, Hutchins H, Sears B. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J Neurosurg. 2011;114:77-84.
64. Bailes JE, Mills J. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J Neurotrauma. 2010;27:1617-24.
65. Wu A, Ying Z, Gomez-Pinilla F. Exercise facilitates the action of dietary DHA on functional recovery after brain trauma. Neuroscience. 2013;248:655-63.
66. Wu A, Ying Z, Gomez-Pinilla F. Dietary strategy to repair plasma membrane after brain trauma: implications for plasticity and cognition. Neurorehabil Neural Repair. 2014;28:75-84.
67. Shin SS, Bray ER, Zhang CQ, Dixon CE. Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats. Brain Res. 2011;1369:208-15.
68. Gómez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci. 2008;9:568-78.
69. Danthi SJ, Enyeart J, Enyeart J. Modulation of native T-type calcium channels by omega-3 fatty acids. Biochem Biophys Res Commun. 2005;327:485-93.
70. Wang X, Zhao X, Mao Z, Wang X, Liu Z. Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures. Neuroreport. 2003;14:2457-61.
71. Högyes E, Nyakas C, Killiaan A, Farkas T, Penke B, Luiten P. Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience. 2003;119:999-1012.
72. Cao DH, Xu J, Xue R, Zheng W, Liu Z. Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav. 2004;79:651-9.
73. Lu DY, Tsao Y, Leung Y, Su K. Docosahexaenoic acid suppresses neuroimflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology. 2010;35:2238-48.
74. Bazan NG. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res. 2009;50(Suppl):S400-5.
75. Cole GM, Frautschy S. DHA may prevent age-related dementia. J Nutr. 2010;140:869-74.
76. Bazan NG. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids. 2009;81:205-11.
77. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83 (Suppl 6):1467S-76S.
78. Chen CT, Liu Z, Bazinet RP. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study. J Neurochem. 2011;116:363-73.
79. Chen CT, Liu Z, Ouellet M, Calon F, Bazinet RP. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukot Essent Fatty Acids. 2009;80:157-63.
80. Chen CT, Domenichiello AF, Trepanier MO, Liu Z, Masoodi M, Bazinet RP. The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms. J Lipid Res. 2013; 54:2410-22.
81. O'Connor WT, Smyth A, Gilchrist MD. Animal models of traumatic brain injury: a critical evaluation. Pharmacol Ther. 2011;130:106-13.
82. Manley GT, Maas AI. Traumatic brain injury: an international knowledgebased approach. JAMA. 2013;310:473-4.
83. Yuh EL, Mukherjee P, Lingsma HF, Yue JK, Ferguson AR, Gordon WA, Valadka AB, Schnyer DM, Okonkwo DO, Maas AI, et al. Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury. Ann Neurol. 2013;73:224-35.
84. Okonkwo DO, Yue JK, Puccio AM, Panczykowski DM, Inoue T, McMahon PJ, Sorani MD, Yuh EL, Lingsma HF, Maas AI, et al. GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the Prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. J Neurotrauma. 2013;30:1490-7.
85. Guskiewicz KM, Mihalik JP, Shankar V, Marshall SW, Crowell DH, Oliaro SM, Ciocca MF, Hooker DN. Measurement of head impacts in collegiate football players: relationship between head impact biomechanics and acute clinical outcome after concussion. Neurosurgery. 2007;61:1244-52.
86. European Food Safety Authority. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J. 2010;8:1461.
87. U.S. Department of Agriculture, U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: U.S. Government Printing Office; 2010.
88. Kris-Etherton PM, Innis S, American Dietetic Association, Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc. 2007;107:1599-611. Erratum in: J Am Diet Assoc. 2007;107:2151.
89. Simopoulos AP, Leaf A, Salem N Jr. Workshop statement on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2000;63:119-21.
90. Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association Nutrition Committee. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23:151-2.
91. U.S. Department of Agriculture, Agricultural Research Service. Nutrient intakes from food: mean amounts consumed per individual, by gender and age. What we eat in America, NHANES 2009-2010 [cited 2013 Nov 1]. Available from: http://www.ars.usda.gov/ba/bhnrc/fsrg.
92. Sears B, Bailes J, Asselin B. Therapeutic uses of high-dose omega-3 fatty acids to treat comatose patients with severe brain injury. PhamaNutrition. 2013;1:86-9.
93. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers 2005 [cited 2013 Dec 18]. Available from: http://www.fda.gov/downloads/Drugs/Guidances/UCM078932.pdf.